Additionally, we found that there was increased susceptibility between GSTM1 null genotype and lung carcinoma risk in different phase I isoenzymes of CYP1A1. These results not only further confirm our conclusion, but also imply some enlightenments. Here, GSTM1 is linked to lung carcinoma.